Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.

Abstract

PURPOSE Medical treatment of glaucoma relies on intraocular pressure (IOP)-lowering medications, typically administered daily by the patient. While these medications are effective when applied correctly, patient adherence is a major obstacle in glaucoma treatment. We have developed a sustained-release formulation of timolol maleate that can be injected… (More)
DOI: 10.1089/jop.2016.0042

Topics

5 Figures and Tables

Cite this paper

@article{Lavik2016SustainedDO, title={Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.}, author={Erin Baker Lavik and Markus K{\"u}hn and Andrew Shoffstall and Kristyn T Atkins and Alina V. Dumitrescu and Young H. Kwon}, journal={Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics}, year={2016}, volume={32 10}, pages={642-649} }